Skip to main content

Table 2 Patient Questionnaire and clinical measures

From: Decline in health-related quality of life and foot and ankle patient reported outcomes measures in patients with haemophilia and ankle haemarthropathy

Outcomes

Severe haemophilia (n = 214)

Moderate haemophilia (n = 29)

HAEMO-QoL-A Total index Score

35.3 (14.9)

35.8 (17.4)

  Physical function

48.6 (11.6)

42.3 (13.9)

  Role Function

31.3 (23.0)

26.1 (23.3)

  Worry

27.0 (25.5)

25.8 (26.0)

  Consequence of bleeding

29.4 (23.1)

31.7 (26.5)

  Emotional impact

56.5 (18.6)

59.1 (19.7)

  Treatment concerns

23.6 (25.0)

30.1 (30.5)

MOXFQ Total score

50.5 (24.2)

45.8 (24.7)

  Social

6.9 (4.0)

5.3 (4.0)

  Pain

9.9 (4.9)

9.5 (5.1)

  Walking/ standing

16.4 (8.0)

14.5 (8.0)

NPRS average ankle pain in the past 6 months

5.0 (2.6)

5.5 (SD,2.5)

Ankle HJHS (left/ right)*

6.0 (3.0; 10.0)/ 5.0(2.0; 9.0)

HA 6.0 (3.0;10.0)/ 6.0 (2.0;9.0)

HB 5.0 (2.0; 9.0)/ 3.0 (0;6.0)*

4.5 (1; 12.5/ 3.0 (0 9.5)

Ankle haemarthropathy (one/both)

103 (48.1%)/ 104 (48.6%)

16 (55.2%)/ 13 (44.8%)

Elbow haemarthropathy (one/both)

77 (36%)/ 26 (12.1%)

7 (24.1%)/ 3 (10.3%)

Knee Haemarthropathy (one/ both)

55 (25.7%)/ 15 (7%)

8 (27.6%)/ 4 (13.8%)

  1. NPRS Nunmerical pain rating scale, SD Standard deviation, IQR Interquartile range (25 and 75 percentile)